Rv Group

What Rv Group does

RV Group is a Singapore-headquartered multinational pharmaceutical company with operational presence across ASEAN, CIS, South Asia, and Middle East/Africa markets. The firm reports between 2,000 and 3,500+ employees across 7 to 9 countries, supporting a portfolio that spans branded prescription drugs, generics, OTC analgesics and cold/flu products, food supplements, medical devices, and dermatology SKUs. Therapeutic areas of focus include hepatology (Hepbest, Myvelpa, Teravir AF, Tafsafe), antiretroviral therapy for HIV (Acriptega, Avonza), oncology (Abevmy, Hertraz, Zometa), gastrointestinal (Refix, Rapeed, Amebismo), anti-diabetic (Duotrol), and a broad Tydol analgesic family.

The group operates four business lines: pharmaceutical distribution of multinational partner brands (Mylan, Cipla, Servier, Merck, Sandoz, Sanbe) into India and Vietnam; generic drug manufacturing through OPV Pharmaceuticals JSC at EU-GMP and WHO GMP-certified facilities in Vietnam (acquired July 2021) plus additional plants in India (7 manufacturing facilities in total); API supply to major Vietnamese pharma companies; and contract development and manufacturing organization (CDMO) services covering tablet, capsule, sachet, liquid, and unidose formats. R&D is described as compliant with ISO and ICH Guideline Q8 international standards. Customers are reached via direct hospital/healthcare-facility sales for prescription products, pharmacy chains and retail pharmacies across Vietnam, and regional distribution partners in ASEAN and CIS. Marketing channels include medical seminars, pharmacy education programs, email newsletters, brand-ambassador partnerships (Miss World Vietnam 2023), and humanitarian partnerships (Red Cross Society Vietnam for Typhoon Bualoi relief).

Revenue is generated through product sales (branded and generic prescription drugs, OTC, food supplements, dermatology) and CDMO professional services. The company is privately held with no institutional investors disclosed; key subsidiaries include OPV Pharmaceuticals JSC (wholly owned, 2021) and RV Lifesciences Limited. No revenue, funding, or valuation data are publicly disclosed.

Name

Rv Group

Legal name

CÔNG TY TNHH RV GROUP VIỆT NAM

Website

https://rvgroups.co

Company type

Private

Founded year

2005

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

RV Group is a Singapore-headquartered multinational pharmaceutical company that distributes, manufactures, and markets branded and generic drugs, OTC products, and supplements across 9 countries in ASEAN, CIS, South Asia, and Africa. It operates 7 manufacturing facilities and serves hepatology, ARV, oncology, and consumer health segments.

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (424210)

SIC

Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Small-Molecule CMC Documentation & Regulatory Support (DMF/CMC) (HLAGAHAM)

Keywords

• Pharmaceutical manufacturing
• Drug distribution
• Contract manufacturing
• Generic medicines
• Pharmaceutical R&D

Headquarters

HQ city

Ho Chi Minh City

HQ country

Vietnam

HQ region

Asia

Offices4 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales

Revenue model

1. Pharmaceutical Distribution: Distribution of branded pharmaceutical products from multinational partners (Mylan, Cipla, Servier, Merck, Sandoz) across India and Vietnam markets
2. Generic Drug Manufacturing: Manufacturing and sale of generic pharmaceutical products through owned EUGMP facilities in India and Vietnam
3. API Supply: Supply of high quality Active Pharmaceutical Ingredients to major pharma companies in Vietnam
4. Contract Manufacturing (CDMO): CDMO services providing comprehensive support from development phase through commercial scale manufacturing

Go-to-market motion2 records

Distribution channels4 records

Marketing channels6 records

Core offering

RV Group is a multinational pharmaceutical company that manufactures and distributes generic and branded pharmaceutical products across therapeutic areas including hepatology, antiretroviral (ARV), oncology, gastrointestinal, anti-diabetic, and OTC/consumer health. The company operates 7 advanced manufacturing facilities across India and Vietnam (EUGMP and WHO GMP certified), supplies Active Pharmaceutical Ingredients (APIs), and provides Contract Development and Manufacturing Organization (CDMO) services to pharmaceutical partners such as Mylan, Cipla, Servier, Merck, and Sandoz.

Product overview

RV Group is a multinational pharmaceutical company headquartered in Singapore with significant presence in ASEAN and CIS regions. The company operates across multiple therapeutic areas including Hepatitis, Anti-Retro Viral (ARV), Oncology, Gastroenterology, Anti-Diabetics, and OTC products. Key therapeutic brands include Hepbest, Teravir AF, Tafsafe, Acriptega, Avonza (ARV/Hepatitis); Abevmy, Hertraz, Zometa (Oncology); and Tydol family analgesics. The company also offers consumer health products (Ameflu cold/flu, Star throat/cough products, Dizzo supplements) and operates manufacturing facilities in India and Vietnam with 7 advanced manufacturing plants. In 2021, RV Group acquired OPV Pharmaceuticals JSC, upgrading it to EU-GMP standards. The company supplies to major pharmaceutical companies in Vietnam and distributes products across 9 countries.

Differentiator

Problem solved

Functional benefit

Brands

• OPV (OPV CDMO): Contract development and manufacturing organization (CDMO) services including tablet, capsule, sachet and liquid production lines, compliant with WHO GMP and EU-GMP standards
• OPV Manufacturing Unit

Products and services

• Hepbest Antiviral medication for hepatitis treatment, distributed as a prescription drug in Vietnam and ASEAN markets.
• Myvelpa Prescription antiviral drug for hepatitis management, distributed by RV Group.
• Acriptega Antiretroviral medication for HIV treatment, part of RV Group's ARV portfolio.
• Teravir AF ARV medication for HIV management.
• Tafsafe ARV medication for HIV treatment.
• Avonza Antiretroviral combination therapy for HIV/AIDS management.
• Abevmy Biosimilar medication for cancer treatment distributed by RV Group.
• Hertraz Oncology medication available in 150mg and 440mg dosages for cancer treatment.
• Refix Gastrointestinal therapeutic product.
• Tydol Analgesics Range OTC and prescription analgesic brand family covering multiple dosages (80mg to 650mg sachets/tablets), with specialized variants including Tydol Plus (enhanced formula with Miss World Vietnam 2023 brand ambassador), Tydol PM (with sleep-aid), Tydol Women (menstrual pain), and Tydol Codeine/Codeine Forte (moderate to severe pain).
• Ameflu Cold and Flu Range OTC cold and flu medications including Ameflu Day Time and New Ameflu Day Time +C (enhanced formulation with Vitamin C).
• Tydol Plus Brand Ambassador Campaign Marketing initiative for Tydol Plus featuring Miss World Vietnam 2023 Huynh Tran Y Nhi as brand ambassador, promoting women's health awareness.
• OPV CDMO Services Contract Development and Manufacturing Organization (CDMO) services provided by OPV Pharmaceuticals JSC, including tablet, capsule, sachet and liquid production lines compliant with WHO GMP and EU-GMP standards. Supports clients from scale-up through validation to commercial production.
• API Supply Supply of high quality Active Pharmaceutical Ingredients (APIs) to major pharmaceutical companies in Vietnam.
• OPV Unidose Liquid Line Unidose (single-dose) liquid product line for nutraceuticals and herbal products with measured single-dose packaging for dietary supplements targeting children and adults. Available in Vietnam pharmacy chains and retail pharmacies.

Quantifiable outcome

• 20+ years of sustainable development in pharmaceutical industry
• +2 more outcomes

Named customers8 records

Segments5 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

One partnership is on record.

• Red Cross Society VietnamminorStrategic or Co-development PartnerRV Group partnered with Red Cross Society Vietnam to provide emergency relief during Typhoon Bualoi in 2025, supplying medicines and essential supplies to affected provinces in north and central Vietnam

Scale indicators6 records

Recent moves7 records

Expansion highlights6 records

Broad incumbents

• Sanofi: Global pharmaceutical major with consumer health, vaccines and specialty care. Sanofi competes broadly with RV Group in Vietnam across chronic disease, OTC and consumer health, but at a vastly different scale and breadth.
• Merck: Multinational pharmaceutical and life sciences company. Merck is both an RV Group distribution partner and a broader incumbent competing in the same therapeutic and consumer health categories across Vietnam and ASEAN.

Direct peers

• Cipla: Indian global generic major with leadership in ARV, respiratory and oncology. RV Group both partners with and competes against Cipla in Vietnam's ARV and hepatitis categories, making Cipla the most directly comparable large-scale peer in the same therapeutic and geographic footprint.
• Pymepharco: One of Vietnam's largest domestic generic pharmaceutical manufacturers, with a broad portfolio across antibiotics, cardiovascular and OTC. Directly comparable as a Vietnam-headquartered pharma combining local manufacturing, distribution and branded generics serving the same pharmacy and hospital channels as RV Group.
• Viatris (formerly Mylan): Global generic and biosimilar major with deep ARV and hepatitis portfolios. Listed as an RV Group distribution partner, Viatris is a direct competitor in the same therapeutic categories across ASEAN and CIS markets.
• Hovid Berhad: Malaysian-based generic pharmaceutical manufacturer with ASEAN and emerging-market distribution presence. Comparable to RV Group in combining own-brand generics, contract manufacturing and regional export channels across Southeast Asia.
• Recipharm: European-headquartered CDMO serving small-molecule, sterile and biologics clients. Comparable to RV Group's OPV CDMO unit in business model (contract manufacturing from scale-up to commercial), with Recipharm representing the larger, more global benchmark.
• Sandoz (Novartis): Global generic and biosimilar division of Novartis, focused on antibiotics, oncology biosimilars and cardiovascular generics. A partner of RV Group and a competing supplier of biosimilars (Hertraz-class) in Asian markets.
• Imexpharm: Vietnamese pharmaceutical manufacturer with broad generic portfolio and EUGMP-certified capacity. Directly comparable as a domestic Vietnamese manufacturer-distributor targeting the same hospital and pharmacy channels.
• DHG Pharmaceutical: Leading Vietnamese pharmaceutical manufacturer with deep domestic distribution across pharmacy chains and hospitals. Competes head-to-head with RV Group in Vietnamese generics, OTC and distribution partnerships with multinational pharma companies.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/RVGroupVN
• LinkedInlinkedin.com/company/rvgroup

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Rv Group